HomeCompareCIGMF vs MRK

CIGMF vs MRK: Dividend Comparison 2026

CIGMF yields 275.86% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIGMF wins by $867.80M in total portfolio value
10 years
CIGMF
CIGMF
● Live price
275.86%
Share price
$0.73
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$867.86M
Annual income
$506,605,582.39
Full CIGMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CIGMF vs MRK

📍 CIGMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIGMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIGMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIGMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIGMF
Annual income on $10K today (after 15% tax)
$23,448.28/yr
After 10yr DRIP, annual income (after tax)
$430,614,745.03/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CIGMF beats the other by $430,606,148.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIGMF + MRK for your $10,000?

CIGMF: 50%MRK: 50%
100% MRK50/50100% CIGMF
Portfolio after 10yr
$433.96M
Annual income
$253,307,848.09/yr
Blended yield
58.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CIGMF
No analyst data
Altman Z
3.8
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIGMF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIGMFMRK
Forward yield275.86%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$867.86M$57.7K
Annual income after 10y$506,605,582.39$10,113.78
Total dividends collected$830.61M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIGMF vs MRK ($10,000, DRIP)

YearCIGMF PortfolioCIGMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$38,286$27,586.21$11,213$373.04+$27.1KCIGMF
2$139,674$98,707.59$12,667$512.06+$127.0KCIGMF
3$485,993$336,542.16$14,439$708.14+$471.6KCIGMF
4$1,614,399$1,094,386.73$16,640$988.16+$1.60MCIGMF
5$5,124,973$3,397,565.75$19,432$1,394.07+$5.11MCIGMF
6$15,563,818$10,080,096.57$23,057$1,992.90+$15.54MCIGMF
7$45,262,468$28,609,183.37$27,889$2,894.79+$45.23MCIGMF
8$126,188,608$77,757,766.98$34,518$4,286.29+$126.15MCIGMF
9$337,622,966$202,601,155.48$43,912$6,494.35+$337.58MCIGMF
10$867,862,156$506,605,582.39$57,714$10,113.78+$867.80MCIGMF

CIGMF vs MRK: Complete Analysis 2026

CIGMFStock

CI Games S.A. produces, publishes, and distributes video games in Europe, North and South America, Asia, and Africa. The company primarily publishes own and licensed first-person shooter and role playing games for various platforms, such as PlayStation, Xbox platforms, and PCs. It sells games directly to retail chains and online through digital distribution channels. The company was formerly known as City Interactive S.A. and changed its name to CI Games S.A. in August 2013. CI Games S.A. was founded in 2002 and is headquartered in Warsaw, Poland.

Full CIGMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CIGMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIGMF vs SCHDCIGMF vs JEPICIGMF vs OCIGMF vs KOCIGMF vs MAINCIGMF vs JNJCIGMF vs ABBVCIGMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.